MedTrace Logo

Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Patients With Lymphoma

NCT03969381 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-05-31

No results posted yet for this study

Summary

* The goal of this study is to determine the feasibility of the diffusion weighted Magnetic Resonance Imaging in the evaluation of the treatment response in patients with malignant lymphoma.
* The investigator's objective is to compare the changes of mean Apparent Diffusion Coefficient value of the tumor with the changes of maximum Standardized Uptake Value of the tumor in positron Emission Tomography Computed Tomography in both pre and post therapy status .

Conditions

Interventions

RADIATION

diffusion weighted magnetic resonance image in lymphoma

compare between result of positron emission tomography /computed tomography and diffusion weighted imaging in followup of lymphoma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • sara, Msc · Assiut University

Eligibility

Min Age
8 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2021-12-30
Completion
2022-01-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03969381 on ClinicalTrials.gov